Irl B. Hirsch, MD - Program Co-Chair
University of Washington School of Medicine
Davida F. Kruger, MSN, APN-BC, BC-ADM - Program Co-Chair
Henry Ford Health System
STATEMENT OF INDEPENDENCE
As a provider of continuing medical education (CME) accredited by the Accreditation Council for Continuing Medical Education, the Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of the Endocrine Society's Special Programs Committee (SPC). The commercial supporter(s) of this activity have no influence over the planning of this CME activity.
DISCLOSURE POLICY
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent CME planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion.
The following faculty reported the following relevant financial relationship(s) during the content development process for this activity:
Irl B. Hirsch, MD (Co-Chair), has served as a research investigator for Beta Bionics, Medtronic Diabetes and Insulet and as a consultant/advisory board for Abbot Diabetes Care and Big Foot Biomedical.
Davida F. Kruger, MSN, APN-BC, BC-ADM (Co-Chair), has served on advisory boards and/or speaker bureaus for Abbott Diabetes Care, Dexcom, Eli Lilly and Company, Novo Nordisk, Pendulum Life, sanofi-aventis U.S. LLC, and Xeris.
The following peer reviewer reported no relevant financial relationship: Andjela Drincic, MD.
Endocrine Society staff associated with the development of content for this activity reported no relevant financial relationships.
The Endocrine Society staff have reviewed all disclosures and resolved or managed all relevant identified conflicts of interest, as applicable.
ACKNOWLEDGEMENT OF COMMERCIAL SUPPORT
This education activity is supported by an independent medical educational grant from Abbott Diabetes Care, Inc., Dexcom, Inc., Helmsley Charitable Trust, Insulet Corporation, Lilly USA, Medtronic Diabetes, and Tandem Diabetes Care.